Bayer AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other
pharmaceutical manufacturers in Europe:
sales of 34.86 billion Euro [US$37.05 billion]
of which 85%
Roche Holding Aktiengesellschaft
(48.15 billion Swiss Francs [US$47.81 billion]
of which 78%
was Pharmaceuticals), and
based in Switzerland
(48.55 billion Swiss Francs [US$48.22 billion]
of which 60%
Bayer AG reported sales of 46.32 billion Euro (US$49.23 billion)
December of 2015.
increase of 9.7%
versus 2014, when the company's sales were 42.24 billion Euro.
Sales at Bayer AG have increased during each of the previous five years
(and since 2010, sales have increased a total of 32%).
Sales of Consumer Care saw an increase
15.2% in 2015, from
7.92 billion Euro to 9.13 billion Euro.
Not all segments of Bayer AG experienced an increase in sales in 2015:
sales of Reconciliations fell 42.9% to 4.00 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).
Bayer AG also experienced decreases in sales in
All Other Segments (down 1.3% to 1.10 billion Euro)